Skip to main content

Written question asked by Helen Hayes (Labour) on Tuesday, 19 March 2019, in the House of Commons. It was due for an answer on Friday, 22 March 2019 (named day). It was answered by Steve Brine (Conservative) on Friday, 22 March 2019 on behalf of the Department of Health and Social Care.


Medical Laboratory Scientific Officers: Resignations

Question

To ask the Secretary of State for Health and Social Care, how many biomedical scientists left hospital screening laboratories in (a) 2018 and (b) 2019; and what steps his Department is taking to ensure laboratories retain highly skilled staff.

Answer

No figures are available specifically for biomedical scientists within screening laboratories, however, the available figures state that there were 1,505 leavers from the selected Healthcare Scientist Care Setting group in National Health Service trusts and clinical commissioning groups over the period 30 September 2017 to 30 September 2018. This staff group includes healthcare scientists within a care setting of blood sciences, cellular sciences, genetics and infection sciences.

The NHS Long Term Plan sets out specific workforce actions developed by NHS Improvement and others to have positive impact for workforces, including the screening and diagnostic workforce. NHS Improvement and the Department will discuss these actions when the education and training budget for Health Education England is set in 2019. This includes a proposal to recruit an additional 1,500 clinical and diagnostic staff across seven priority specialisms between 2018 and 2021.

Professor Sir Mike Richards is leading a major review of national cancer screening programme pathways as part of the NHS Long Term Plan’s renewed drive to improve care and save lives. Professor Richards’ review is due later this year.

Specifically, in relation to cervical cancer screening, to maintain the service and accommodate current staffing levels, a majority of existing pilot sites carrying out the new human papilloma virus (HPV) testing and some non-pilot sites have already converted more of their cervical screening activity to HPV primary screening, freeing up cytology capacity.


Secondary information

Type
Written question
Reference
234241
Session
2017-19
Subjects
Medical laboratory scientific officers Resignations
Contains statistics
Yes
Link
View this Written question on www.parliament.uk